2017 NCCN Case Manager and Medical Director Program: Updates in the Diagnosis and Treatment of Colon Cancer

November 1, 2017

Join Wells A. Messersmith, MD, University of Colorado Cancer Center as he presents Updates in the Diagnosis and Treatment of Colon Cancer as part of the NCCN 2017 Oncology Case Manager and Medical Director Program Webinar Series.

Making optimal treatment decisions for patients with colon cancer involves consideration of how the possible risks and benefits of the various therapeutic options apply to the individual patient’s values, preferences, and disease characteristics. Case managers and other health professionals involved in care planning and coordination need to be knowledgeable about all the treatment options, molecular testing recommendations, and other considerations for patients with colon cancer so they can discuss their risks, benefits, and appropriateness with each patient. Such discussions allow for informed decision making, which can enable patients to receive optimal care that maximizes their survival and comfort while taking into account their values and preferences.

Target Audience

This program is designed to meet the educational needs of case managers, nurses in other roles (i.e., quality management and utilization review), medical directors at managed care organizations, reinsurers, TPAs, and case management and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care and/or make coverage decisions. Programs may also be of interest to nurses, nurse navigators/care coordinators, and physicians who work directly with patients in clinical settings as well as clinical pharmacists in managed care organizations and other settings.

Learning Objectives

Following this activity, participants should be able to:

  • Provide an overview of the therapeutic options for patients with colon cancer.
  • Describe important disease and patient characteristics used to inform treatment decisions in patients with colon cancer.
  • Discuss survivorship care as it applies to those treated for colon cancer.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Astellas and Medivation, Inc., a Pfizer Company
  • AstraZeneca
  • Genentech
  • Genomic Health, Inc.
  • Olympus Corporation of the Americas
  • Taiho Oncology
  • Takeda Oncology

This activity is supported by independent educational grants from AbbVie and Boehringer Ingelheim Pharmaceuticals, Inc.

Course summary
Available credit: 
  • 1.25 CCM clock hours
  • 1.25 ACPE contact hours
  • 1.25 ANCC contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Participation
Course opens: 
09/05/2017
Course expires: 
01/02/2018
Event starts: 
11/01/2017 - 12:15pm
Event ends: 
11/01/2017 - 1:30pm
Cost:
$0.00

Wells A. Messersmith, MD
University of Colorado Cancer Center

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Physicians
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 hour of Category I credits for completing this activity.

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.25 contact hours.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. Credit approval for case managers is pending for this program. If approved, Activity Code and Approval Number will be posted prior to activity date.

Pharmacists

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 1.25 contact hours (0.125 CEUs) of continuing education credit. Universal Activity Number (UAN) will be posted prior to activity date.

Available Credit

  • 1.25 CCM clock hours
  • 1.25 ACPE contact hours
  • 1.25 ANCC contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Participation

Accreditation Period

Course opens: 
09/05/2017
Course expires: 
01/02/2018

Price

Cost:
$0.00
Please login or register to take this course.

Click the Take Course button to register for this live webinar.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing